Titan Pharmaceuticals, Inc. (TTNP): Price and Financial Metrics


Titan Pharmaceuticals, Inc. (TTNP)

Today's Latest Price: $0.17 USD

0.01 (3.09%)

Updated Sep 25 4:00pm

Add TTNP to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 373 in Biotech

See all "A" rated Strong Buy stocks

TTNP Stock Summary

  • With a market capitalization of $16,527,941, Titan Pharmaceuticals Inc has a greater market value than only 7.16% of US stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 6.75 for Titan Pharmaceuticals Inc; that's greater than it is for 83.59% of US stocks.
  • Titan Pharmaceuticals Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -118.88%, greater than the shareholder yield of just 3.68% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Titan Pharmaceuticals Inc are ESLT, RNWK, LEDS, NEON, and SPNS.
  • Visit TTNP's SEC page to see the company's official filings. To visit the company's web site, go to www.titanpharm.com.
TTNP Daily Price Range
TTNP 52-Week Price Range

TTNP Stock Price Chart Technical Analysis Charts


TTNP Price/Volume Stats

Current price $0.17 52-week high $0.59
Prev. close $0.16 52-week low $0.14
Day low $0.17 Volume 4,214,566
Day high $0.17 Avg. volume 11,945,316
50-day MA $0.25 Dividend yield N/A
200-day MA $0.26 Market Cap 16.53M

Titan Pharmaceuticals, Inc. (TTNP) Company Bio


Titan Pharmaceuticals, Inc., a specialty pharmaceutical company, develops proprietary therapeutics for the treatment of serious medical disorders in the United States. The company was founded in 1992 and is based in South San Francisco, California.


TTNP Latest News Stream


Event/Time News Detail
Loading, please wait...

TTNP Latest Social Stream


Loading social stream, please wait...

View Full TTNP Social Stream

Latest TTNP News From Around the Web

Below are the latest news stories about Titan Pharmaceuticals Inc that investors may wish to consider to help them evaluate TTNP as an investment opportunity.

Titan Pharma prices $2.7M direct offering

Titan Pharmaceuticals (TTNP) slips 4.7% in premarket after announcement of a share purchase agreement with certain accredited institutional investors to purchase ~19.4M shares in a registered direct offering at $0.14/share, with net proceeds of ~$2.5M.The offering is expected to close by September 28....

Seeking Alpha | September 24, 2020

Titan Pharmaceuticals Announces Pricing of $2.7 Million Registered Direct Offering

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) today announced it has entered into a share purchase agreement with certain accredited institutional investors to purchase 19,440,000 shares of its common stock in a registered direct offering at a purchase price of $0.14 per share.

Yahoo | September 24, 2020

Titan Pharmaceuticals' increases authorized shares

In its special meeting, Titan Pharmaceuticals (TTNP) stockholders' approved the proposal to amend its certificate of incorporation to increase the number of authorized shares of common stock from 125M to 225M.Quick look at the company's common shares outstanding:...

Seeking Alpha | September 18, 2020

Titan Pharmaceuticals' Stockholders Approve Proposal To Amend Its Certificate Of Incorporation

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") announced that, at today's special meeting, its stockholders approved the proposal to amend Titan's certificate of incorporation to increase the number of authorized shares of common stock from 125 million to 225 million (the "Amendment").

Yahoo | September 18, 2020

Titan's Probuphine® Commercialization Partner, Molteni, Enters Into Exclusive European Distribution Agreement With Accord Healthcare

SOUTH SAN FRANCISCO, Calif., Sept. 15, 2020 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that its partner, Molteni Farmaceutici ("Molteni"), has entered into an exclusive distribution agreement with Accord Healthcare Europe…

PR Newswire | September 15, 2020

Read More 'TTNP' Stories Here

TTNP Price Returns

1-mo -28.27%
3-mo -49.84%
6-mo -37.73%
1-year -41.78%
3-year -98.33%
5-year -99.22%
YTD -12.42%
2019 -85.30%
2018 -83.40%
2017 -66.88%
2016 -9.91%
2015 74.73%

Continue Researching TTNP

Here are a few links from around the web to help you further your research on Titan Pharmaceuticals Inc's stock as an investment opportunity:

Titan Pharmaceuticals Inc (TTNP) Stock Price | Nasdaq
Titan Pharmaceuticals Inc (TTNP) Stock Quote, History and News - Yahoo Finance
Titan Pharmaceuticals Inc (TTNP) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.683 seconds.